Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging

The global market for contract pharmaceutical manufacturing, research and packaging services should grow from $168.0 billion in 2021 to $214.7 billion by 2026, at a compound annual growth rate (CAGR) of 5.0% during the forecast period of 2021-2026.

Report Includes

• 35 data tables
• An updated review of the global market for pharmaceutical and biopharmaceutical contract manufacturing, research and packaging services within the industry
• Analyses of the global market trends, with data from 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026
• Evaluation of market size and market forecast for global pharmaceutical contract research, manufacturing, and packaging services market, and their corresponding market share analysis by type, dosage form, formulation, application, and geographic region
• Discussion of key market dynamics (DROs), technological advancements, product launches, and regulatory landscape in the context of contract manufacturing and contract pharmaceutical research services
• Impact of COVID-19 on pharmaceutical supply chain and outsourcing practices affecting the progress of this market
• Market outlook and opportunity assessment of the contract manufacturing industry structure, and evaluation of ongoing clinical trials and R&D activities estimating current and future market demand
• Insight into the growth development strategies of the key market players operating within the global market; their key competitive landscape and company share analysis
• Descriptive company profiles of the major market players, including 3M Co., AbbVie, Albany Molecular Research Inc. (AMRI), Baxter International Inc., Boehringer Ingelheim, Dr Reddy’s Laboratories Ltd., Lonza Group, Jubilant Life Sciences Ltd., Pfizer CentreOne, and Takeda Pharmaceuticals

The global market for pharmaceutical contract manufacturing, contract research and contract packaging will grow from $136.4 billion in 2017 to $197.0 billion by 2022 with a compound annual growth rate (CAGR) of 7.6% for the period of 2017-2022.

Report Includes

• 50 data tables
• An overview of the global market for contract pharmaceutical manufacturing, research, and packaging, with emphasis on the outlook of the market and a comprehensive analysis of the overall pharmaceutical and biotechnology outsourcing industry
• Analyses of global market trends, with data from 2015, 2016, and 2017, and projections of compound annual growth rates (CAGRs) through 2022
• Examination of the effects on market growth of state-of-the-art packaging facilities, as well as expensive research facilities and the capabilities of research organizations
• Coverage of the market's need for outsourcing, the regulatory environment, and technological issues, including the latest trends and developments
• Profiles of major companies in the market, including AbbVie Contract Manufacturing, Alkermes Plc, Catalent Inc., Dishman Pharmaceuticals and Chemicals Limited, Jubilant Life Sciences Limited and Norwich Pharma Services

The global market for contract pharmaceutical manufacturing, research and packaging totaled $248.5 billion in 2014 and is projected to approach $352.8 billion by 2019, registering a compound annual growth rate (CAGR) of 7.3% through 2019.

Report Includes

• An overview of the global market for contract pharmaceutical manufacturing, research, and packaging, with emphasis on the current and future outlook of the market and a comprehensive analysis of the overall pharmaceutical and biotechnology outsourcing industry.
• Analyses of global market trends, with data from 2013 and 2014, and projections of compound annual growth rates (CAGRs) through 2019.
• Examination of the effects on market growth of state-of-the-art packaging facilities as well as expensive research facilities and the capabilities of research organizations.
• Coverage of the market's need for outsourcing, the regulatory environment, and technological issues, including the latest trends and developments.
• Comprehensive company profiles of major players.

The global market for pharmaceutical and biopharmaceutical contract manufacturing, research and packaging was $219.9 billion in 2012. This market is estimated to reach $242.2 billion in 2013 and $374.8 billion by 2018, a five-year compound annual growth rate (CAGR) of 9.1%.

Report Includes

• An overview of the global market for contract pharmaceutical manufacturing, research, and packaging, with emphasis on the current and future outlook of the market and a comprehensive analysis of the overall pharmaceutical and biotechnology outsourcing industry.
• Analyses of global market trends, with data from 2011 and 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
• Examination of the effects on market growth of state-of-the-art packaging facilities as well as expensive research facilities and the capabilities of research organizations.
• Coverage of the market's need for outsourcing, the regulatory environment, and technological issues, including the latest trends and developments.
• Comprehensive company profiles of major players.

The global pharmaceutical contract manufacturing and contract research organizations revenue reached $196.5 billion in 2010, and it will further grow to $217.9 billion in 2011. The market is projected to reach $360.6 billion by 2016, increasing at a compound annual growth rate (CAGR) of 10.6%.

• Overall sales in the pharmaceutical contract manufacturing and contract research market were worth nearly $143 billion in 2007, which increased to an estimated $177 billion in 2009. By 2014, sales are projected to increase to nearly $299 billion, for a 5-year CAGR of 11.1%.
• The largest segment in the market, contract manufacture of OTC and nutraceuticals, was valued at $82 billion in 2007. This increased to an estimated $103 billion in 2009, and is projected to reach $177 billion in 2014, for a 5-year CAGR of 11.4%.
• Sales in the contract manufacture of bulk- and dosage-form drugs segment were worth $36 billion in 2007, and were to increase to nearly $44 billion in 2009. By 2014, they are projected to increase to $73 billion, for a 5-year CAGR of 10.8%..

• Worldwide revenue for contract manufacture of prescription drugs (dosage forms) for 2004 was $11.1 billion, which is projected to increase at a compound annual growth rate (CAGR) of 9.4%, reaching $22.5 billion by the end of 2011.
• Contract manufacture of over-the-counter and nutritional products worldwide is projected to reach $108.8 billion by 2011 increasing at a CAGR of 8.1%. Contract research revenues are projected to reach $24.3 billion by 2011, increasing from $17.3 billion in 2006 at a CAGR of 7.0%.
• Contract manufacturing in the bulk drug market had worldwide revenue of about $13.5 billion in 2004.

• Worldwide revenue for contract manufacturing and research for the pharmaceutical industry was estimated at $100 billion in 2004 and is expected to rise at an average annual growth rate (AAGR) of 10.8% to $168 billion in 2009.
• Contract manufacturing of prescription drugs for 2004 was estimated at $26.2 billion, and is expected to rise to $43.9 billion by end of 2009.
• Contract manufacturing of OTC and nutritional products is the largest and fastest growing segment, expected to rise at an AAGR of 11.3% to $102 billion by 2009.
• The contract research market is expected to reach $21.9 billion by 2009, rising at an AAGR of 8.6% from $ 14.5 billion in 2004.